GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,830,000 | -33.3% | 44,835 | -46.1% | 0.12% | -51.0% |
| Q1 2020 | $4,246,000 | +95.1% | 83,105 | +203.5% | 0.25% | +188.5% |
| Q4 2019 | $2,176,000 | -54.1% | 27,380 | -69.4% | 0.09% | -51.1% |
| Q1 2019 | $4,740,000 | +26.9% | 89,545 | -1.6% | 0.18% | +11.9% |
| Q4 2018 | $3,736,000 | – | 91,015 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |